scholarly journals A prospective study on effectiveness of elevated intraocular pressure as a criterion for glaucoma referrals by optometric practitioners in Sweden

2021 ◽  
Author(s):  
Karin Landgren ◽  
Dorothea Peters
2021 ◽  
Vol 10 (16) ◽  
pp. 3472
Author(s):  
Bojan Pajic ◽  
Mirko Resan ◽  
Brigitte Pajic-Eggspuehler ◽  
Horace Massa ◽  
Zeljka Cvejic

Background: The aim of the study is to investigate whether the circadian IOP rhythm can be influenced by combined cataract surgery with high frequency deep sclerotomy (HFDS) and whether intraocular pressure (IOP) can be significantly reduced by HFDS. Methods: In our study 10 patients were included, in whom 24 h IOP monitoring was installed before and after HFDS/cataract surgery using a Triggerfish. HFDS is a minimally invasive glaucoma surgery (MIGS). Results: After performed HFDS combined with cataract surgery, the IOP was reduced from 27.7 ± 2.11 mmHg to 14.4 ± 2.59 mmHg, which is highly significant (p < 0.001). The contact lens sensor (CLS) cosinor analysis pre- and postoperatively showed that the circadian rhythm is not influenced by the surgery, i.e., the circadian IOP rhythm did not show significant differences before and after surgery. Conclusions: HFDS combined with cataract surgery is a potent surgical method that can significantly reduce the IOP. However, the circadian rhythm cannot be changed by the surgery. The acrophase remained during the night in all patients.


2019 ◽  
Vol 44 (6) ◽  
pp. 623-631 ◽  
Author(s):  
Claudio I. Perez ◽  
Sunee Chansangpetch ◽  
Anwell Nguyen ◽  
Max Feinstein ◽  
Marta Mora ◽  
...  

2017 ◽  
Vol 35 (1) ◽  
pp. 116-123 ◽  
Author(s):  
Ivano Riva ◽  
Andreas Katsanos ◽  
Francesco Oddone ◽  
Luciano Quaranta

2011 ◽  
Vol 89 (5) ◽  
pp. e466-e471 ◽  
Author(s):  
Pascal Bruno Knecht ◽  
Martina Monika Bosch ◽  
Stephan Michels ◽  
Sönke Mannhardt ◽  
Ursina Schmid ◽  
...  

2015 ◽  
Vol 233 (3-4) ◽  
pp. 176-185 ◽  
Author(s):  
José Juan Escobar-Barranco ◽  
Begoña Pina-Marín ◽  
Manel Fernández-Bonet

Purpose: To assess the effect of dexamethasone (DEX) 0.7 mg (Ozurdex™) on refractory and treatment-naïve diffuse diabetic macular edema. Methods: A prospective study was conducted in 76 patients (40 refractory and 36 naïve) with visual acuities (VA) of 15-72 ETDRS letters, central macular thickness (CMT) >300 µm and intraocular pressure (IOP) <25 mm Hg. After the DEX implant (±photocoagulation), VA, CMT and total macular volume (TMV) were assessed monthly for 6 months. Results: At every visit, VA improved significantly from baseline (p < 0.001) in both groups, but values were significantly better in the naïve group, while CMT and TMV decreased significantly (p < 0.001) and similarly in both groups. The naïve group received more photocoagulations (p = 0.001). There were 7.9% transient IOP increases >10 mm Hg. Conclusions: Substantial improvements in VA and CMT were achieved in both groups, and a gain of 1 ETDRS line was observed in the treatment-naïve group as compared to the refractory group, with a good safety profile in both.


Sign in / Sign up

Export Citation Format

Share Document